Third Annual Conference of the Neurosurgery Innovation and Translation Branch of China Association of Geriatric Health Successfully Concludes with the Final Review of the 'Shen Ji Miao Shu' 2023 Neurosurgical Innovation Awards

2The Third Conference of the Neurosurgery Innovation and Translation Branch of the China Association of Health Care for the Elderly, along with the Final Review Meeting of the “Shenji Miaoshu” 2023 Neurosurgical Innovative Technology Evaluation, was successfully held in Hefei from November 30 to December 1, 2023. The conference was guided by the Hefei Municipal Development and Reform Commission, hosted by the China Association of Health Care for the Elderly and its Neurosurgery Innovation and Translation Branch, and co-hosted by VCBeat and VB100.

This timeThe conference was“Empowering Innovative Development in Neurosurgery, Promoting the Construction of a Healthy China” was the theme. Adhering to the mission of driving innovation and translation in neurosurgery, enhancing diagnostic and therapeutic standards and outcomes, and providing better medical services for patients, the event established a platform for in-depth exchange and win-win collaboration among neurosurgical professionals and innovative enterprises in the field. This was achieved through the release of a White Paper on Neurosurgical Medical Devices, the presentation of the 2023 National “Shenji Miaoshu” (Ingenious Devices and Techniques) Innovation Technology Awards in neurosurgery, and sharing sessions by past award winners to discuss their innovative experiences.

The conference, withOpening of the 2023 “Shenji Miaoshu” Final Review Meeting on Innovative Technologies in NeurosurgeryBuilding upon approximately eight months of rigorous preliminary and secondary reviews, the final round featured nine finalists. Following insightful commentary and discussions by a panel of renowned neurosurgical experts and leading specialists in medical translation across China, a cohort of outstanding medical translation projects with significant innovation and clinical application value was selected. Among them, the Golden Incubation Fund was awarded to the project “Artificial Bionic Vestibule,” submitted by Dr. Ren Pengyu from the Second Affiliated Hospital of Xi’an Jiaotong University. Attending scholars and experts noted that the technological sophistication of projects participating in the society’s review process continues to rise, with artificial intelligence featuring prominently in many entries, aligning with current cutting-edge technological trends. There is a shared belief that, supported by the society’s innovation and translation platform, these projects will drive new breakthroughs in neurosurgical diagnosis and treatment technologies.

This conference brings togetherNeurosurgeons, scholars, healthcare professionals, corporate representatives, and engineers from across China engaged in sincere and pragmatic exchanges. During the keynote session, Mr. Wan Changqing, Deputy Director of the Hefei Municipal Development and Reform Commission, enthusiastically presented an overview of Hefei’s scientific research and innovation landscape. He affirmed the Hefei Municipal Government’s steadfast support for the translation of medical innovations into clinical applications, pledging to continuously enhance policy frameworks to support innovative diagnostics and treatments, thereby fostering a more favorable environment for entrepreneurship and academic advancement.

(Wan Changqing, Hefei Municipal Development and Reform Commission)

Professor Zhang Jianning, Honorary President of the Society, affirmed the Society’s steady development and commended its unwavering commitment to promoting translational medicine. He praised the Society for encouraging neurosurgeons, particularly young neurosurgeons, to actively engage in innovation through initiatives such as showcases of innovative translational achievements.

(Zhang JianningGeneral Hospital of Tianjin Medical University）

Mr. Jiang Tianjiao, Dean of VCBeat Institute, prominently unveiled the latest achievements of this year’s conference, highlighting its focus on the publication of medical big data.----White Paper on Neurosurgical Medical Devices: As the first white paper in the field of neurosurgical medical devices, it comprehensively, thoroughly, and adequately presents the current development trajectory, market prospects, opportunities, and challenges of neurosurgical medical devices.

(Jiang Tianjiao, VCBeat)

President Jiang Rongcai provided a comprehensive overview of the original intent, key contents, and significance behind the compilation and release of the white paper. He expressed his hope that the history of neurosurgery in China would prominently document the significant contributions made by neurosurgical medical device companies in introducing international new technologies, advancing the discipline of neurosurgery, and aligning with global standards. He called upon neurosurgeons to identify issues in clinical diagnosis and treatment, actively contemplate solutions, collaborate with experts in medical innovation translation and innovative enterprises, play a leading role in China’s medical device innovation, and emphasize the importance of translational medicine. He pledged that the Society would establish a robust ecosystem for medical innovation, paving the way for neurosurgeons in translational efforts and building a bridge between clinical practice and scientific research translation. Furthermore, he welcomed the participation of capital investors and engineers, expressing confidence in the great potential of medical innovation.

（Jiang Rongcai Tianjin Medical University General Hospital）

Annual Meeting forThe 2023 award-winning innovative projects were honored in a grand ceremony, which invited leading Chinese neurosurgical experts from various fields—including craniocerebral trauma, glioma, cerebrovascular disease, spinal neurosurgery, and functional neurosurgery—to exchange insights on the latest research findings and technological applications, while providing comprehensive overviews and future outlooks for innovation within their respective subspecialties.Experts unanimously agree that, with continuous technological advancements and the transformation of medical models, strengthening technological innovation and translational applications to promote the sustained development of neurosurgery is not only the driving force behind its vigorous growth but also an essential pathway for China’s neurosurgery to catch up with and surpass international advanced standards.

The conference also invited experts from domestic innovative neurosurgical medical device companies to introduce new methods and technologies in their respective fields, fully demonstrating that the demand for innovation and translation in neurosurgery is the driving force behind corporate progress. It also provided a preliminary understanding of the difficulties and persistence entrepreneurs face on the path of medical device innovation. Their innovations and efforts are actively bridging the gap between the needs of doctors and patients and the innovation sector, injecting vibrant vitality into the development of neurosurgery. Several young neurosurgeons from major hospitals across China, who have already achieved successful attempts in innovation translation, also shared their experiences in the innovation translation process and insights into future innovation directions. Through exchanges and interactions with clinical translation experts and investors, they provided valuable experience for the future innovation and translation efforts of all attending young doctors and entrepreneurs. The conference, in exploring neurosurgeryThe roundtable discussion on the new mechanism for translating “medical-research-enterprise” achievements into practical applications concluded successfully.

The successful convening of this conference has provided experts, scholars, and healthcare professionals in the field of neurosurgery, corporate representatives, and engineers have provided a robust communication platform that will further drive innovation and translation of neurosurgical medical device technologies in China. Participants in the academic exchanges and project reviews includedMore than 30 renowned experts and scholars in the field of neurosurgery in China, along with dozens of young neurosurgeons, medical translation regulatory experts, investors, patent commercialization specialists, and representatives from innovative enterprises. The Society’s efforts to build a platform for innovation and translation in neurosurgery left a deep impression on the attending experts and leaders, who all expressed their commitment to enhancing academic exchanges as much as possible in the future, contributing to the advancement of neurosurgery in China.